Trending
- Hope for families with hereditary cancer risk
- A novel hybrid transformer-based framework (H-ConvNeXt–Swin) to classify brain tumors using MRI
- Withdrawal Planned for Second-Line Lurbinectedin in SCLC Indication
- What Limits Pediatric Oncology Trial Access for Marginalized Families?
- Why Self-Care Matters Most When You Have No Time
- CARTITUDE-4 Supports Earlier CAR-T Use in Relapsed/Refractory Multiple Myeloma
- Clinical Implications of Earlier CAR-T Therapy in Relapsed/Refractory Multiple Myeloma
- RAF1 extrachromosomal DNA amplification confers acquired erlotinib resistance in a non-small cell lung cancer cell model
Wednesday, August 5